Clinical trials
Neuromyelitis Optica trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 3 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 7 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospices Civils de Lyon | 4 |
| Alexion Pharmaceuticals, Inc. | 3 |
| Hoffmann-La Roche | 2 |
| Ad scientiam | 1 |
| Amgen | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Assistance Publique Hopitaux De Marseille | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Imcyse SA | 1 |
| University Hospital Center of Martinique | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuromyelitis Optica | 18 |
| Multiple Sclerosis | 8 |
| Optic Neuritis | 4 |
| Demyelinating Diseases | 2 |
| Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease | 2 |
| Myelitis | 2 |
| Alzheimer Disease | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Atypical Hemolytic Uremic Syndrome | 1 |
| Autoimmune Diseases | 1 |
Trials
Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.